| Real-time Estimate
Cboe Europe 05:21:55 2026-09-21 am EDT |
5-day change | 1st Jan Change | ||
| 9.778 SEK | -2.22% | |
-2.71% | -53.51% |
Published on 09/21/2026 at 04:28 am EDT
Finwire – Translated by Marketscreener
Legal disclaimer
Contact us to request a correction
– See original
So far today, 15 new 52-week lows have been recorded across the Stockholm Stock Exchange’s lists.
The check was made at around 10:21 a.m.
| Stock | New 52-week low | Previous 52-week low | Previous date |
| AAK | 184,40 | 185,20 | 2026-09-18 |
| Avensia | 5,54 | 5,56 | 2026-09-18 |
| Björn Borg | 56,10 | 56,20 | 2026-09-18 |
| C.A.G Group | 88,40 | 89,00 | 2026-09-18 |
| Corline Biomedical | 13,75 | 13,95 | 2026-09-11 |
| Combinedx | 25,60 | 28,00 | 2026-03-30 |
| Dometic Group | 21,22 | 21,24 | 2026-09-18 |
| Devyser | 52,30 | 52,90 | 2026-09-18 |
| EMB Mission Bound | 0,426 | 0,430 | 2026-02-27 |
| Emilshus | 44,50 | 45,30 | 2026-09-18 |
| Orexo | 12,70 | 12,72 | 2026-09-17 |
| Qliro Group | 16,30 | 16,39 | 2025-12-16 |
| Saniona | 9,73 | 9,93 | 2026-09-18 |
| Senzime | 2,66 | 2,77 | 2026-09-18 |
| W5 Solutions | 30,00 | 30,50 | 2026-09-18 |
| Source: FactSet |
Saniona AB is a Sweden-based company active in the field of biotechnology. It operates in the area of drugs targeting ion channels to develop therapeutics for pain, central nervous system, and inflammatory or autoimmune diseases. The Company develops a technology platform which enables investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors and potassium channels. The clinical pipeline includes: AN788, a clinical candidate for second line treatment of major depressive disorder (MDD); AN761, to be developed for cognition deficits in schizophrenia and Alzheimer’s disease; AN363, a candidate for treatment of pain disorders; and AN346, an anti-inflammatory treatment in inflammatory bowel disease (IBD); as well as several other projects. The Company is engaged in partnerships with Janssen Pharmaceuticals Inc, Pfizer Inc and Atlas Venture Inc.
Select your edition
All financial news and data tailored to specific country editions
